US EditionCompany to begin clinical trials of 'revolutionary' accommodating IOL
Summary by Insight
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Company to begin clinical trials of 'revolutionary' accommodating IOL
A Canadian firm claims its accommodating IOL could help cataract patients focus on near and far objects. Image: StockPhotoPro/adobe.stock.com.Canadian ophthalmic technology company Ocumetics Technology Corp has announced that it is undertaking what it claims is the first-in-human (FIH) clinical studies of its “revolutionary” accommodating intraocular lens. “This moment is nothing short of transformational,” said Mr Dean Burns, CEO of Ocumetics, …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
